Protease-inhibitor cocktail protects, increases anti-microbial action of promising new peptide Peer-Reviewed Publication. University at Buffalo ...

The anti-microbial activity of promising peptides shown in laboratory studies to kill several medically important fungi, some of which are resistant to current drugs, can be enhanced further by ...

WebMD provides information about interactions between ombitasvir-paritaprevir-ritonavir-dasabuvir oral and cobicistat-protease-inhibitors-salmeterol. Skip to main content Check Your Symptoms ...

Two experimental drugs that block a key enzyme in the replication of the hepatitis C virus promise to bring an improvement in therapy for infections with the virus ...

Cocrystal Pharma Inc (NASDAQ: COCP) has announced laboratory-based results for its lead preclinical SARS-CoV-2 3CL protease inhibitor, CDI-45205. A third-party laboratory contracted by Cocrystal ...

Add articles to your saved list and come back to them any time. Fulfilling a long-held goal of AIDS researchers, US federal regulators have approved the first anti-HIV drug that requires patients ...

Over a year of follow-up (with some patients lost to follow-up in both groups) 12% (18/153) of participants taking PIs and 22% (61/283) of those in the non-PI group contracted COVID-19 assessed by ...